These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24379737)

  • 1. Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?
    Saracyn M; Brodowska-Kania D; Niemczyk S
    ScientificWorldJournal; 2013 Nov; 2013():170576. PubMed ID: 24379737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
    J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in dialysis patients: time to abandon warfarin?
    Brancaccio D; Neri L; Bellocchio F; Barbieri C; Amato C; Mari F; Canaud B; Stuard S
    Int J Artif Organs; 2016 May; 39(3):99-105. PubMed ID: 27079417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?
    Vázquez E; Sánchez-Perales C; García-Cortes MJ; Borrego F; Lozano C; Guzmán M; Gil JM; Liébana A; Pérez P; Borrego MJ; Pérez V
    Int J Cardiol; 2003 Feb; 87(2-3):135-9; discussion 139-41. PubMed ID: 12559531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts.
    Xu Y; Shoamanesh A; Schulman S; Dowlatshahi D; Al-Shahi Salman R; Moldovan ID; Wells PS; AlKherayf F
    PLoS One; 2018; 13(1):e0191137. PubMed ID: 29370183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
    Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2875-88. PubMed ID: 24169613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.
    Genovesi S; Rebora P; Gallieni M; Stella A; Badiali F; Conte F; Pasquali S; Bertoli S; Ondei P; Bonforte G; Pozzi C; Rossi E; Valsecchi MG; Santoro A
    J Nephrol; 2017 Aug; 30(4):573-581. PubMed ID: 27834042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding.
    Little DHW; Sutradhar R; Cerasuolo JO; Perez R; Douketis J; Holbrook A; Paterson JM; Gomes T; Siegal DM
    CMAJ; 2021 Mar; 193(9):E304-E309. PubMed ID: 33649169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?
    Parker K; Mitra S; Thachil J
    Br J Haematol; 2018 Jun; 181(6):725-736. PubMed ID: 29468649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhausting multiple hemodialysis access failures.
    Bolleke E; Seferi S; Rroji M; Idrizi A; Barbullushi M; Thereska N
    Med Arch; 2014 Oct; 68(5):361-3. PubMed ID: 25568574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.
    Hu A; Niu J; Winkelmayer WC
    Semin Nephrol; 2018 Nov; 38(6):618-628. PubMed ID: 30413255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Zaman JAB; Bhandari AK
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):499-508. PubMed ID: 31284744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI).
    Königsbrügge O; Lorenz M; Auinger M; Schmaldienst S; Klauser-Braun R; Kletzmayr J; Grilz E; Posch F; Antlanger M; Pabinger I; Säemann M; Ay C
    Thromb Res; 2017 Oct; 158():59-64. PubMed ID: 28843824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation.
    Franchi C; Antoniazzi S; Proietti M; Nobili A; Mannucci PM;
    Br J Clin Pharmacol; 2018 Sep; 84(9):2010-2019. PubMed ID: 29745441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
    Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dabigatran treatment simulation in patients undergoing maintenance haemodialysis.
    Liesenfeld KH; Clemens A; Kreuzer J; Brueckmann M; Schulze F
    Thromb Haemost; 2016 Mar; 115(3):562-9. PubMed ID: 26467062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion].
    Merella P; Casu G; Mazzone P; Lorenzoni G; D'Angelo G; Genovesi S
    G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and warfarin use in haemodialysis patients: an individualized holistic approach is important in stroke prevention.
    Thet Z; Vilayur E
    Nephrology (Carlton); 2013 May; 18(5):331-9. PubMed ID: 23521615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.